Dana Fuller
Family Medicine · Clinton, SCNPI 1578125837
Payments from drug & device makers
Across 104 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$351
- GSK$254
- AbbVie$224
- Pfizer$151
- Idorsia Pharmaceuticals US Inc$122
- Takeda Pharmaceuticals U.S.A., Inc.$110
- plus $562 from 15 others
What the payments were for
- Food & beverage$1,775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $351 |
| GSK | 14 | $254 |
| AbbVie | 14 | $224 |
| Pfizer | 8 | $151 |
| Idorsia Pharmaceuticals US Inc | 7 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $110 |
| Lilly USA, LLC | 7 | $108 |
| Abiomed | 1 | $69 |
| AstraZeneca | 3 | $46 |
| Novartis | 3 | $44 |
| Merck | 3 | $39 |
| Exact Sciences | 2 | $39 |
| Amgen | 2 | $36 |
| Dexcom, Inc. | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Organon | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,775 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $21,847 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $553 |
| Atorvastatin Calcium | 31 | $368 |
| Pravastatin Sodium | 20 | $310 |
| Levothyroxine Sodium | 21 | $291 |
| Amlodipine Besylate | 25 | $286 |
| Diclofenac Sodium | 13 | $259 |
| Metformin Hcl | 17 | $208 |
| Fluoxetine Hcl | 17 | $159 |
| Famotidine | 17 | $152 |
| Lisinopril | 20 | $151 |
| Omeprazole | 14 | $108 |
| Hydrochlorothiazide | 13 | $80 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $70 |
| Trazodone Hcl | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $351 | $21,84718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Clinton
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.